Cargando…

Intravenous Thrombolysis Before Mechanical Thrombectomy for Acute Ischemic Stroke: A Meta‐Analysis

BACKGROUND: Whether intravenous thrombolysis before mechanical thrombectomy provides additional benefit for functional outcome in acute ischemic stroke remains uncertain. We performed a meta‐analysis to compare the outcomes of direct mechanical thrombectomy (dMT) to mechanical thrombectomy with brid...

Descripción completa

Detalles Bibliográficos
Autores principales: Du, Houwei, Lei, Hanhan, Ambler, Gareth, Fang, Shuangfang, He, Raoli, Yuan, Qilin, Werring, David J., Liu, Nan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9075352/
https://www.ncbi.nlm.nih.gov/pubmed/34779235
http://dx.doi.org/10.1161/JAHA.121.022303
_version_ 1784701663146147840
author Du, Houwei
Lei, Hanhan
Ambler, Gareth
Fang, Shuangfang
He, Raoli
Yuan, Qilin
Werring, David J.
Liu, Nan
author_facet Du, Houwei
Lei, Hanhan
Ambler, Gareth
Fang, Shuangfang
He, Raoli
Yuan, Qilin
Werring, David J.
Liu, Nan
author_sort Du, Houwei
collection PubMed
description BACKGROUND: Whether intravenous thrombolysis before mechanical thrombectomy provides additional benefit for functional outcome in acute ischemic stroke remains uncertain. We performed a meta‐analysis to compare the outcomes of direct mechanical thrombectomy (dMT) to mechanical thrombectomy with bridging using intravenous thrombolysis (bridging therapy [BT]) in patients with acute ischemic stroke. METHODS AND RESULTS: We performed a literature search in the PubMed, Excerpta Medica database, and Cochrane Central Register of Controlled Trials from January 1, 2003, to April 26, 2021. We included randomized clinical trials and observational studies that reported the 90‐day functional outcome in patients with acute ischemic stroke undergoing dMT compared with BT. The 12 included studies (3 randomized controlled trials and 9 observational studies) yielded 3924 participants (mean age, 68.0 years [SD, 13.1 years]; women, 44.2%; 1887 participants who received dMT and 2037 participants who received BT). A meta‐analysis of randomized controlled trial and observational data revealed similar 90‐day functional independence (odds ratio [OR], 1.04; 95% CI, 0.90–1.19), mortality (OR, 1.03; 95% CI, 0.78–1.36), and successful recanalization (OR, 0.93; 95% CI, 0.76–1.14) for patients treated with dMT or BT. Compared with those in the BT group, patients in the dMT group were less likely to experience symptomatic intracranial hemorrhage (OR, 0.68; 95% CI, 0.51–0.91; P=0.008) or any intracranial hemorrhage (OR, 0.71; 95% CI, 0.61–0.84; P<0.001). CONCLUSIONS: In this meta‐analysis of patients with acute ischemic stroke, we found no significant differences in 90‐day functional outcome or mortality between dMT and BT, but a lower rate of symptomatic intracranial hemorrhage for dMT. These findings support the use of dMT without intravenous thrombolysis bridging therapy. REGISTRATION: URL: https://www.crd.york.ac.uk/prospero/; Unique identifier: 42021234664.
format Online
Article
Text
id pubmed-9075352
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-90753522022-05-10 Intravenous Thrombolysis Before Mechanical Thrombectomy for Acute Ischemic Stroke: A Meta‐Analysis Du, Houwei Lei, Hanhan Ambler, Gareth Fang, Shuangfang He, Raoli Yuan, Qilin Werring, David J. Liu, Nan J Am Heart Assoc Systematic Review and Meta‐analysis BACKGROUND: Whether intravenous thrombolysis before mechanical thrombectomy provides additional benefit for functional outcome in acute ischemic stroke remains uncertain. We performed a meta‐analysis to compare the outcomes of direct mechanical thrombectomy (dMT) to mechanical thrombectomy with bridging using intravenous thrombolysis (bridging therapy [BT]) in patients with acute ischemic stroke. METHODS AND RESULTS: We performed a literature search in the PubMed, Excerpta Medica database, and Cochrane Central Register of Controlled Trials from January 1, 2003, to April 26, 2021. We included randomized clinical trials and observational studies that reported the 90‐day functional outcome in patients with acute ischemic stroke undergoing dMT compared with BT. The 12 included studies (3 randomized controlled trials and 9 observational studies) yielded 3924 participants (mean age, 68.0 years [SD, 13.1 years]; women, 44.2%; 1887 participants who received dMT and 2037 participants who received BT). A meta‐analysis of randomized controlled trial and observational data revealed similar 90‐day functional independence (odds ratio [OR], 1.04; 95% CI, 0.90–1.19), mortality (OR, 1.03; 95% CI, 0.78–1.36), and successful recanalization (OR, 0.93; 95% CI, 0.76–1.14) for patients treated with dMT or BT. Compared with those in the BT group, patients in the dMT group were less likely to experience symptomatic intracranial hemorrhage (OR, 0.68; 95% CI, 0.51–0.91; P=0.008) or any intracranial hemorrhage (OR, 0.71; 95% CI, 0.61–0.84; P<0.001). CONCLUSIONS: In this meta‐analysis of patients with acute ischemic stroke, we found no significant differences in 90‐day functional outcome or mortality between dMT and BT, but a lower rate of symptomatic intracranial hemorrhage for dMT. These findings support the use of dMT without intravenous thrombolysis bridging therapy. REGISTRATION: URL: https://www.crd.york.ac.uk/prospero/; Unique identifier: 42021234664. John Wiley and Sons Inc. 2021-11-15 /pmc/articles/PMC9075352/ /pubmed/34779235 http://dx.doi.org/10.1161/JAHA.121.022303 Text en © 2021 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Systematic Review and Meta‐analysis
Du, Houwei
Lei, Hanhan
Ambler, Gareth
Fang, Shuangfang
He, Raoli
Yuan, Qilin
Werring, David J.
Liu, Nan
Intravenous Thrombolysis Before Mechanical Thrombectomy for Acute Ischemic Stroke: A Meta‐Analysis
title Intravenous Thrombolysis Before Mechanical Thrombectomy for Acute Ischemic Stroke: A Meta‐Analysis
title_full Intravenous Thrombolysis Before Mechanical Thrombectomy for Acute Ischemic Stroke: A Meta‐Analysis
title_fullStr Intravenous Thrombolysis Before Mechanical Thrombectomy for Acute Ischemic Stroke: A Meta‐Analysis
title_full_unstemmed Intravenous Thrombolysis Before Mechanical Thrombectomy for Acute Ischemic Stroke: A Meta‐Analysis
title_short Intravenous Thrombolysis Before Mechanical Thrombectomy for Acute Ischemic Stroke: A Meta‐Analysis
title_sort intravenous thrombolysis before mechanical thrombectomy for acute ischemic stroke: a meta‐analysis
topic Systematic Review and Meta‐analysis
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9075352/
https://www.ncbi.nlm.nih.gov/pubmed/34779235
http://dx.doi.org/10.1161/JAHA.121.022303
work_keys_str_mv AT duhouwei intravenousthrombolysisbeforemechanicalthrombectomyforacuteischemicstrokeametaanalysis
AT leihanhan intravenousthrombolysisbeforemechanicalthrombectomyforacuteischemicstrokeametaanalysis
AT amblergareth intravenousthrombolysisbeforemechanicalthrombectomyforacuteischemicstrokeametaanalysis
AT fangshuangfang intravenousthrombolysisbeforemechanicalthrombectomyforacuteischemicstrokeametaanalysis
AT heraoli intravenousthrombolysisbeforemechanicalthrombectomyforacuteischemicstrokeametaanalysis
AT yuanqilin intravenousthrombolysisbeforemechanicalthrombectomyforacuteischemicstrokeametaanalysis
AT werringdavidj intravenousthrombolysisbeforemechanicalthrombectomyforacuteischemicstrokeametaanalysis
AT liunan intravenousthrombolysisbeforemechanicalthrombectomyforacuteischemicstrokeametaanalysis